» Articles » PMID: 38424172

Elucidating Hepatocellular Carcinoma Progression: a Novel Prognostic MiRNA-mRNA Network and Signature Analysis

Overview
Journal Sci Rep
Specialty Science
Date 2024 Feb 29
PMID 38424172
Authors
Affiliations
Soon will be listed here.
Abstract

There is increasing evidence that miRNAs play an important role in the prognosis of HCC. There is currently a lack of acknowledged models that accurately predict patient prognosis. The aim of this study is to create a miRNA-based model to precisely forecast a patient's prognosis and a miRNA-mRNA network to investigate the function of a targeted mRNA. TCGA miRNA dataset and survival data of HCC patients were downloaded for differential analysis. The outcomes of variance analysis were subjected to univariate and multivariate Cox regression analyses and LASSO analysis. We constructed and visualized prognosis-related models and subsequently used violin plots to probe the function of miRNAs in tumor cells. We predicted the target mRNAs added those to the String database, built PPI protein interaction networks, and screened those mRNA using Cytoscape. The hub mRNA was subjected to GO and KEGG analysis to determine its biological role. Six of them were associated with prognosis: hsa-miR-139-3p, hsa-miR-139-5p, hsa-miR-101-3p, hsa-miR-30d-5p, hsa-miR-5003-3p, and hsa-miR-6844. The prognostic model was highly predictive and consistently performs, with the C index exceeding 0.7 after 1, 3, and 5 years. The model estimated significant differences in the Kaplan-Meier plotter and the model could predict patient prognosis independently of clinical indicators. A relatively stable miRNA prognostic model for HCC patients was constructed, and the model was highly accurate in predicting patients with good stability over 5 years. The miRNA-mRNA network was constructed to explore the function of mRNA.

Citing Articles

Extracellular vesicle miRNAs from three-dimensional ovarian cancer in vitro models and their implication in overall cancer survival.

Godbole N, Lai A, Carrion F, Scholz-Romero K, Ravichandran A, Kalita-de Croft P Heliyon. 2025; 11(4):e42188.

PMID: 40034306 PMC: 11872480. DOI: 10.1016/j.heliyon.2025.e42188.


Identification of pyroptosis-associated miRNAs in the immunoscape and prognosis of hepatocellular carcinoma.

Zheng Y, Huang X BMC Cancer. 2024; 24(1):1513.

PMID: 39695414 PMC: 11657507. DOI: 10.1186/s12885-024-13276-5.


Risk factors and clinical prediction models for low-level viremia in people living with HIV receiving antiretroviral therapy: an 11-year retrospective study.

Zhang W, Shi J, Wang Y, Li E, Yan D, Zhang Z Front Microbiol. 2024; 15:1451201.

PMID: 39552647 PMC: 11563986. DOI: 10.3389/fmicb.2024.1451201.

References
1.
Prajapati K, Shuaib M, Kushwaha P, Singh A, Kumar S . Identification of cancer stemness related miRNA(s) using integrated bioinformatics analysis and in vitro validation. 3 Biotech. 2021; 11(10):446. PMC: 8460704. DOI: 10.1007/s13205-021-02994-3. View

2.
Lou W, Liu J, Ding B, Chen D, Xu L, Ding J . Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC. J Transl Med. 2019; 17(1):7. PMC: 6317219. DOI: 10.1186/s12967-018-1761-7. View

3.
Mo Y, Lu Y, Wang P, Huang S, He L, Li D . Long non-coding RNA XIST promotes cell growth by regulating miR-139-5p/PDK1/AKT axis in hepatocellular carcinoma. Tumour Biol. 2017; 39(2):1010428317690999. DOI: 10.1177/1010428317690999. View

4.
Zhang G, Zhang G . Upregulation of FoxP4 in HCC promotes migration and invasion through regulation of EMT. Oncol Lett. 2019; 17(4):3944-3951. PMC: 6425392. DOI: 10.3892/ol.2019.10049. View

5.
Lee Y, Dutta A . MicroRNAs in cancer. Annu Rev Pathol. 2008; 4:199-227. PMC: 2769253. DOI: 10.1146/annurev.pathol.4.110807.092222. View